Canagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyVlado Perkovic, Kenneth W. Mahaffey, Rajiv Agarwal et al.|New England Journal of Medicine|2019Cited by 6k
Congenital Oligonephropathy and the Etiology of Adult Hypertension and Progressive Renal InjuryBarry M. Brenner, Glenn M. Chertow|American Journal of Kidney Diseases|1994Cited by 597
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trialsHiddo J.L. Heerspink, Tom Greene, Hocine Tighiouart et al.|The Lancet Diabetes & Endocrinology|2019Cited by 372
Efficacy and Safety of Angiotensin II Receptor Blockade in Elderly Patients With DiabetesWolfgang C. Winkelmayer, Barry M. Brenner|Diabetes Care|2006Cited by 57